Low grade multiple myeloma that presented as a labial swelling - A case report

British Dental Journal

Volumn 199, Issue 7, 2005, Pages 433-435

  Ariyaratnam, S ^a   Sweet, C ^a   Duxbury, J ^a  

^a UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMYLOIDOSIS; ARTICLE; BIOPSY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LIP TUMOR; MULTIPLE MYELOMA; PATHOLOGY;

AGED; AMYLOIDOSIS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIP NEOPLASMS; MULTIPLE MYELOMA;

EID: 27744605110     PISSN: 00070610     EISSN: 17417503     Source Type: Journal    
DOI: 10.1038/sj.bdj.4812742     Document Type: Article

References (16)

1. nd ed. pp 347-372. New York, Edinburgh, London, Melbourne, Tokyo: Churchill Livingstone, 1991.
2. Barlogie B, Epstein J, Selvanayagam P, Alexanian R. Plasma cell myeloma: New biological insights and advances in therapy. Blood 1989; 73: 965-978.
3. Durie B G M. Multiple myeloma. A concise review of the disease and treatment options. UK: International Myeloma Foundation, Nov 2000.
4. nd Ed. pp 366-367. UK: CV Mosby, 1990.
5. Jagger R G, Helkimo M, Carlsson G E. Multiple myeloma involving the temoromandibular joint. J Oral Surg 1978; 36: 557-559.
6. Breathnach S M. Amyloid and amyloidosis. J Am Acad Dermatol 1988; 18: 1-16.
7. Touart D M, Sau P. Cutaneous deposition diseases. Part 1. J Am Acad Dermatol 1998; 39: 149-171.
8. Stevens F J, Kisilevsky R. Immunoglobulin light chains, glycosaminoglycans, and amyloid. Cell Mol Life Sci 2000; 3: 441-449.
9. Van Der Waal R I F, Van De Scheur M R, Huijgens P C, Starink T M, Van De Waal I. Amyloidosis of the tongue as a paraneoplastic marker of plasma cell dyscrasia. Oral Surg Oral Med Pathol Oral Radiol Endod 2002; 94: 444-447.
10. Gretz M A, Lacy M Q, Dispenzieri A. Amyloidosis. Haematol Oncol Clin North Am 1999; 13: 1211-1233.
11. Durie B G M, Salmon S E. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842-854.
12. Jacobson J L, Hussein M A, Barlogie B, Durie B G M, Crowley J L. A new staging system for multiple myeloma patients based on the southwest oncology group (SWOG) experience. Br J Haematol 2003; 122: 441.
13. Durie B G M, Stock-Novack D, Salmon SE et al. Prognostic value of pre treatment serum B2 microglobulin in myeloma: A South West oncology group study. Blood 1990; 75: 823-830.
14. Kyle R A. 'Benign' monoclonal gammopathy - after 20-35 years follow up. Mayo Clinic Proceedings 1993; 68: 26-36.
15. Alexanian R, Haut A, Khan A et al. Treatment for multiple myeloma: combination chemotherapy with different melphalan dose regimes. J Am Med Asso 1969; 208: 1680-1685.
16. Harousseau J L. Management of multiple myeloma. Rev Clin Exp Haematol 2002; 6: 253-275.